The rising prevalence in GLP-1 agonists for diabetes has generated a question about formats: transdermal systems versus tablets . Traditionally , GLP-1 treatments were exclusively available in oral form, https://kiananwgi654260.bloggactivo.com/40036583/glp-1-skin-applications-vs-oral-medications-what-right-for-you